ACRS
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS) has 18 SEC Form 4 filings (28 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 4, 2026.
Insiders have net sold $1.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Neal S. Walker
- Employees:61
- HQ:Wayne, PA, US
- IPO:2015-10-06
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$825.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Leonard Braden MichaelFirst filing | Insider | Sale | 300,000 | $1.4M | Apr 27 | SEC ↗ |
Related companies
Aclaris Therapeutics, Inc. is in the Healthcare sector.